Is a complete NSE/ORCHPHARMA research report available?

No complete published report is available for nse/ORCHPHARMA (NSE/ORCHPHARMA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/ORCHPHARMA stock profile: metrics, valuation and analysis

Market cap	52B
Revenue (ttm)	8.5B
Net income (ttm)	294.6M
EPS (ttm)	₹5.81
Shares out	50.7M
P/E (trailing)	176.3x
P/E (forward)	53.6x
Volume	121,336
Beta	0.48

All NSE/ORCHPHARMA indicators

Market & fundamental data

Available fields

190

Groups with data

Currency

INR

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	736
Employees Change	-135%
Employees Change Percent	-15.5
Enterprise value	INR 54.8B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	39.64
Industry PE Fwd	33.97
Isin	INE191A01027
Last refreshed	2026-09-10
Market cap	INR 52B
Price	INR 1,030
Price currency	INR
Rev Per Employee	11,580,336.96x
Sector	Healthcare
Sector PE	48.17
Sector PE Fwd	38.6
Sic	2834
Symbol	nse/ORCHPHARMA
Website	https://www.orchidpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.57%
EV Earnings	185.9x
EV/EBIT	231.21x
EV/EBITDA	92.06x
EV/Sales	6.43x
FCF yield	-5.43%
Forward P/E	53.59x
P/B ratio	4.04x
P/E ratio	176.29x
P/S ratio	6.1x
PE Ratio3 Y	78.91x
PE Ratio5 Y	73.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.92%
EBITDA Margin	7.12%
Gross margin	35.85%
Gross Profit	INR 3.1B
Gross Profit Growth	-14.57%
Gross Profit Growth Q	34.84%
Gross Profit Growth3 Y	3.66%
Gross Profit Growth5 Y	10.53%
Net Income	INR 294.6M
Net Income Growth	-65.43%
Net Income Growth Q	-78.38%
Net Income Growth Qo Q	-87.52%
Net Income Growth Years	0%
Net Income Growth3 Y	-25.32%
Pretax Margin	3.44%
Profit Margin	3.46%
Profit Per Employee	INR 400,321
Profitable Quarters	INR 2
Profitable Years	4
Roa5y	1.33
Roe5y	3.67
ROIC	1.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	45.73%
Cagr3y	23.74%
Cagr5y	20.57%
EPS Growth	-65.4
EPS Growth Q	-81.63
EPS Growth Qo Q	-87.47
EPS Growth Years	0
EPS Growth3 Y	-29.12
OCF Growth	426.65%
OCF Growth3 Y	76.71%
OCF Growth5 Y	33.81%
Revenue Growth	0.22x
Revenue Growth Q	75.89x
Revenue Growth Qo Q	-17.42x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	5.89x
Revenue Growth5 Y	15.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 832.1M
Debt	INR 3.6B
Debt EBITDA	INR 5.97
Debt Equity	INR 0.28
Debt FCF	INR -1.28
Equity	INR 12.9B
Interest Coverage	1.89
Net Cash	INR -2.8B
Net Cash By Market Cap	INR -5.37
Net Debt EBITDA	INR 4.6
Net Debt Equity	INR 0.22
Tangible Book Value	INR 12.1B
Tangible Book Value Per Share	INR 239
WACC	6.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	45.7%
200-day SMA	787
3Y total return	89.5%
50-day SMA	999.6
50-day SMA vs 200-day SMA	50over200
5Y total return	154.76%
All Time High	2,654.3
All Time High Change	-61.2%
All Time High Date	2021-04-05
All Time Low	17.5
All Time Low Change	5,784.86%
All Time Low Date	2020-11-03
ATR	45.05
Beta	0.48
Beta1y	0.67
Beta2y	0.42
Ch YTD	35.69
High	1,035
High52	1,133
High52 Date	2026-08-11
High52ch	-9.1%
Low	969.6
Low52	480
Low52 Date	2026-03-30
Low52ch	114.55%
Ma50ch	3.03%
Price vs 200-day SMA	30.86%
RSI	56.98
RSI Monthly	56.62
RSI Weekly	64.27
Sharpe ratio	0.87x
Sharpe Ratio3y	0.55x
Sharpe Ratio5y	0.53x
Sortino ratio	1.61
Sortino Ratio3y	1
Sortino Ratio5y	0.98
Total Return	0.08%
Tr YTD	35.69
Tr1m	2.8%
Tr1w	8.65%
Tr3m	22.23%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	50,718,539%
Net Borrowing	1,718,748,000
Shares Institutions	24.4%
Shares Out	50,719,105
Shares Qo Q	-0.4%
Shares Yo Y	-0.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	79,594.75x
Bv Per Share	254
CAPEX	INR -3.8B
Ch1m	2.8
Ch1w	8.65
Ch1y	45.7
Ch3m	22.23
Ch3y	89.5
Ch5y	154.8
Ch6m	102.5
Change	6.63%
Change From Open	5.54
Close	965.8
Days Gap	1.04
Depreciation Amortization	358,053,000
Dollar Volume	124,957,879.6
Earnings Date	2026-08-14
EBIT	INR 249M
EBITDA	INR 607.1M
EPS	INR 5.81
F Score	3
FCF	INR -2.8B
FCF EV Yield	-5.16x
FCF Per Share	INR -55.68
Financing CF	1,699,803,000
Fiscal Year End	March
Founded	1,992
Graham Number	183.06189
Graham Upside	-82.22
Income Tax	INR -1.2M
Investing CF	-2,852,744,000
Is Primary Listing	1
Last Earnings Date	2026-08-14
Last Report Date	2026-06-30
Lynch Fair Value	INR 29.19
Lynch Upside	-97.17
Ma150	787.9
Ma150ch	30.71%
Ma20	982.4
Ma20ch	4.84%
Net CF	-140,988,000
Open	975.8
P OCF Ratio	51.37
Position In Range	92.13
Price Date	2026-09-09
Price EBITDA	INR 85.62
Ptbv Ratio	4.28
Relative Volume	1.48x
Revenue	8,523,128,000x
Tax By Revenue	-0.01x
Tr6m	102.51%
Volume	121,336

NSE/ORCHPHARMA (NSE/ORCHPHARMA)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/ORCHPHARMA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/ORCHPHARMA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/ORCHPHARMA

Frequently asked questions